Literature DB >> 8653896

Impact of point-of-care testing on patients' length of stay in a large emergency department.

C A Parvin1, S F Lo, S M Deuser, L G Weaver, L M Lewis, M G Scott.   

Abstract

We prospectively investigated whether routine use of a point-of-care testing (POCT) device by nonlaboratory operators in the emergency department (ED) for all patients requiring the available tests could shorten patient length of stay (LOS) in the ED. ED patient LOS, defined as the length of time between triage (initial patient interview) and discharge (released to home or admitted to hospital), was examined during a 5-week experimental period in which ED personnel used a hand-held POCT device to perform Na, K, Cl, glucose (Gluc), and blood urea nitrogen (BUN) testing. Preliminary data demonstrated acceptable accuracy of the hand-held device. Patient LOS distribution during the experimental period was compared with the LOS distribution during a 5-week control period before institution of the POCT device and with a 3-week control period after its use. Among nearly 15 000 ED patient visits during the study period, 4985 patients (2067 during the experimental period and 2918 during the two control periods) had at least one Na, K, Cl, BUN, or Gluc test ordered from the ED. However, no decrease in ED LOS was observed in the tested patients during the experimental period. Median LOS during the experimental period was 209 min vs 201 min for the combined control periods. Stratifying patients by presenting condition (chest pain, trauma, etc.), discharge/admit status, or presence/absence of other central laboratory tests did not reveal a decrease in patient LOS for any patient subgroup during the experimental period. From these observations, we consider it unlikely that routine use of a hand-held POCT device in a large ED such as ours is sufficient by itself to impact ED patient LOS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653896

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

Review 1.  The Evidence to Support Point-of-Care Testing.

Authors:  Andrew St John
Journal:  Clin Biochem Rev       Date:  2010-08

2.  Laboratory turnaround time.

Authors:  Robert C Hawkins
Journal:  Clin Biochem Rev       Date:  2007-11

3.  Point of care testing: randomised controlled trial of clinical outcome.

Authors:  J Kendall; B Reeves; M Clancy
Journal:  BMJ       Date:  1998-04-04

4.  Evidence based practice: clinicians' use and attitudes to near patient testing in hospitals.

Authors:  T A Gray; D B Freedman; D Burnett; A Szczepura; C P Price
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

Review 5.  Turnaround Time (TAT): Difference in Concept for Laboratory and Clinician.

Authors:  Hara P Pati; Gurmeet Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-08       Impact factor: 0.900

6.  Patient Preferences for Point-of-Care Testing: Survey Validation and Results.

Authors:  Craig M Lilly; Emily Ensom; Sean Teebagy; Danielle DiMezza; Denise Dunlap; Nathaniel Hafer; Bryan Buchholz; David McManus
Journal:  Point Care       Date:  2020-12

7.  Evaluation of the i-STAT point-of-care analyzer in critically ill adult patients.

Authors:  Jacoline Steinfelder-Visscher; Steven Teerenstra; Jacqueline M T Klein Gunnewiek; Patrick W Weerwind
Journal:  J Extra Corpor Technol       Date:  2008-03

8.  Improving access to diagnostics: an evaluation of a satellite laboratory service in the emergency department.

Authors:  P Leman; D Guthrie; R Simpson; F Little
Journal:  Emerg Med J       Date:  2004-07       Impact factor: 2.740

9.  Diagnosis of acute serious illness: the role of point-of-care technologies.

Authors:  Gregory L Damhorst; Erika A Tyburski; Oliver Brand; Greg S Martin; Wilbur A Lam
Journal:  Curr Opin Biomed Eng       Date:  2019-09-16

Review 10.  A systematic review of triage-related interventions to improve patient flow in emergency departments.

Authors:  Sven Oredsson; Håkan Jonsson; Jon Rognes; Lars Lind; Katarina E Göransson; Anna Ehrenberg; Kjell Asplund; Maaret Castrén; Nasim Farrohknia
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-07-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.